These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 7237712

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of amrinone on myocardial energy metabolism and hemodynamics in patients with severe congestive heart failure due to coronary artery disease.
    Benotti JR, Grossman W, Braunwald E, Carabello BA.
    Circulation; 1980 Jul; 62(1):28-34. PubMed ID: 7379283
    [Abstract] [Full Text] [Related]

  • 3. Hemodynamic effects of oral pirbuterol in chronic severe congestive heart failure.
    Awan NA, Evenson MK, Needham KE, Evans TO, Hermanovich J, Taylor CR, Amsterdam E, Mason DT.
    Circulation; 1981 Jan; 63(1):96-101. PubMed ID: 7438412
    [Abstract] [Full Text] [Related]

  • 4. Pirbuterol: a new oral sympathomimetic amine for the treatment of congestive heart failure.
    Sharma B, Hoback J, Francis GS, Hodges M, Asinger RW, Cohn JN, Taylor CR.
    Am Heart J; 1981 Sep; 102(3 Pt 2):533-41. PubMed ID: 6115572
    [Abstract] [Full Text] [Related]

  • 5. Hemodynamic and metabolic effects of isosorbide dinitrate in chronic congestive heart failure.
    Gray R, Chatterjee K, Vyden JK, Ganz W, Forrester JS, Swan HJ.
    Am Heart J; 1975 Sep; 90(3):346-52. PubMed ID: 1163426
    [Abstract] [Full Text] [Related]

  • 6. Potential value of oral beta 2-adrenoceptor agonists in congestive heart failure: a haemodynamic and metabolic study.
    Timmis AD, Bergman G, Walker L, Monaghan MJ, Jewitt DE.
    Int J Cardiol; 1984 Mar; 5(3):327-38. PubMed ID: 6706438
    [Abstract] [Full Text] [Related]

  • 7. Flosequinan, a new vasodilator: systemic and coronary hemodynamics and neuroendocrine effects in congestive heart failure.
    Cavero PG, De Marco T, Kwasman M, Lau D, Liu M, Chatterjee K.
    J Am Coll Cardiol; 1992 Dec; 20(7):1542-8. PubMed ID: 1452928
    [Abstract] [Full Text] [Related]

  • 8. The acute hemodynamic response to pirbuterol at rest and exercise in patients with heart failure with observations on long-term response.
    Uretsky BF, Seecof RM, Reddy PS.
    Can J Cardiol; 1986 Dec; 2(2):80-5. PubMed ID: 3085906
    [Abstract] [Full Text] [Related]

  • 9. [Does chronic oral treatment with beta-receptor blockers have an effect on positive inotropic therapy of coronary patients with adrenaline after extracorporeal circulation?].
    Günnicker M, Brinkmann M, Freund U, Piotrowski J, Schieffer M, Velser U.
    Herz; 1995 Dec; 20(6):399-411. PubMed ID: 8582699
    [Abstract] [Full Text] [Related]

  • 10. Myocardial and systemic effects of nitroglycerin, given awake and during anaesthesia in coronary patients.
    Moffitt EA, Sethna DH, Gray RJ, Raymond MJ, Bussell JA, Matloff JM.
    Can Anaesth Soc J; 1983 Jul; 30(4):352-9. PubMed ID: 6409387
    [Abstract] [Full Text] [Related]

  • 11. Effects of atrial natriuretic factor on coronary hemodynamics and myocardial energetics in patients with heart failure.
    Herrmann HC, Palacios IF, Dec GW, Scheer JM, Fifer MA.
    Am Heart J; 1988 Jun; 115(6):1232-8. PubMed ID: 2967626
    [Abstract] [Full Text] [Related]

  • 12. RO13-6438, a new inotrope-vasodilator: systemic and coronary hemodynamic effects in congestive heart failure.
    Daly PA, Chatterjee K, Viquerat CE, Parmley WW, Curran D, Scheinbaum M, Anderson S.
    Am J Cardiol; 1985 Jun 01; 55(13 Pt 1):1539-44. PubMed ID: 4003296
    [Abstract] [Full Text] [Related]

  • 13. Effects of hydralazine on coronary blood flow and myocardial energetics in congestive heart failure.
    Magorien RD, Brown GP, Unverferth DV, Nelson S, Boudoulas H, Bambach D, Leier CV.
    Circulation; 1982 Mar 01; 65(3):528-33. PubMed ID: 7055874
    [Abstract] [Full Text] [Related]

  • 14. A new beta-2 adrenoceptor agonist (pirbuterol) in the treatment of ischaemic heart failure.
    Nelson GI, Silke B, Barker MC, Saxton CA, Taylor SH.
    Eur Heart J; 1982 Jun 01; 3(3):238-45. PubMed ID: 6125392
    [No Abstract] [Full Text] [Related]

  • 15. Systemic and coronary hemodynamic and neurohumoral effects of levodopa in chronic congestive heart failure.
    De Marco T, Daly PA, Chatterjee K.
    Am J Cardiol; 1988 Dec 01; 62(17):1228-33. PubMed ID: 2904216
    [Abstract] [Full Text] [Related]

  • 16. Coronary hemodynamic effects of angiotensin inhibition by captopril and teprotide in patients with congestive heart failure.
    Halperin JL, Faxon DP, Creager MA, Bass TA, Melidossian CD, Gavras H, Ryan TJ.
    Am J Cardiol; 1982 Nov 01; 50(5):967-72. PubMed ID: 6182786
    [Abstract] [Full Text] [Related]

  • 17. Dopexamine hydrochloride in chronic congestive heart failure with improved cardiac performance without increased metabolic cost.
    De Marco T, Kwasman M, Lau D, Chatterjee K.
    Am J Cardiol; 1988 Aug 11; 62(5):57C-62C. PubMed ID: 3407596
    [Abstract] [Full Text] [Related]

  • 18. Effect of enoximone alone and in combination with metoprolol on myocardial function and energetics in severe congestive heart failure: improvement in hemodynamic and metabolic profile.
    Galie N, Branzi A, Magnani G, Melandri G, Caldarera I, Rapezzi C, Grattoni C, Magnani B.
    Cardiovasc Drugs Ther; 1993 Jun 11; 7(3):337-47. PubMed ID: 8364004
    [Abstract] [Full Text] [Related]

  • 19. Effects of ouabain on myocardial oxygen supply and demand in patients with chronic coronary artery disease. A hemodynamic, volumetric, and metabolic study in patients without heart failure.
    DeMots H, Rahimtoola SH, Kremkau EL, Bennett W, Mahler D.
    J Clin Invest; 1976 Aug 11; 58(2):312-9. PubMed ID: 783197
    [Abstract] [Full Text] [Related]

  • 20. Effects of milrinone on coronary hemodynamics and myocardial energetics in patients with congestive heart failure.
    Monrad ES, Baim DS, Smith HS, Lanoue A, Brauwald E, Grossman W.
    Circulation; 1985 May 11; 71(5):972-9. PubMed ID: 3986984
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.